Medicare Enrolled

Dr. Julia Newbold

Nurse Practitioner - Family · Philadelphia, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
6701 RIDGE AVE STE 1, Philadelphia, PA 19128
2154834179
In practice since 2018 (8 years)
NPI: 1225545106 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Newbold from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Newbold? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Newbold

Dr. Julia Newbold is a nurse practitioner - family in Philadelphia, PA, with 8 years of NPI registration. Based on federal Medicare data, Dr. Newbold performed 8,119 Medicare services across 3,335 unique beneficiaries.

Between the years covered by Open Payments, Dr. Newbold received a total of $378 from 4 pharmaceutical and/or device companies across 4 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Newbold is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice ▲ Top 0% volume in PA $378 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,119
Medicare services
Top 0% in PA for nurse practitioner - family
3,335
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,015 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
3,884 $5 $9
Home visit, established patient, moderate complexity
A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service.
784 $86 $178
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
709 $40 $87
Nursing facility visit, moderate complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes.
508 $69 $145
Home visit, established patient, low complexity
A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes.
308 $51 $92
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
250 $66 $131
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
239 $76 $146
Nursing facility visit, low complexity
A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care.
237 $49 $89
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
208 $111 $232
Home visit, established patient, straightforward decision making
A home visit for an established patient involving straightforward medical decision making. The visit lasts at least 15 minutes when time is used to determine the level of service.
195 $31 $51
Home visit, new patient, moderate complexity
A home visit for a new patient involving moderate medical decision making, lasting at least 60 minutes.
180 $94 $204
Nursing facility visit, established patient, straightforward
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes.
130 $27 $45
Home visit, new patient, low complexity
A home visit for a new patient involving a low level of medical decision making. The visit lasts at least 30 minutes when time is used to determine the level of service.
97 $53 $92
Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes 92 $56 $97
Initial nursing facility care, moderate complexity
Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes.
79 $88 $185
Home visit, new patient, low complexity
A home visit for a new patient involving straightforward medical decision making. The visit lasts at least 15 minutes if time is used as the defining factor.
45 $33 $55
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
37 $35 $63
Destruction of cancerous skin growth on face, 1.1-2.0 cm
This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter.
31 $133 $255
Destruction of cancerous skin growth, 2.1-3.0 cm
This procedure involves the removal or destruction of a cancerous skin lesion measuring between 2.1 and 3.0 centimeters located on the trunk, arms, or legs.
26 $132 $256
Destruction of cancer skin growth, 1.1-2.0 cm
Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters.
24 $115 $229
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
17 $80 $184
Destruction of skin growth, 15 or more growths 15 $94 $174
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm 13 $125 $240
Destruction of cancerous skin growth on face, 0.6-1.0 cm
This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter.
11 $106 $240
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$378
Total received (2021-2024)
Avg $189/year across 2 years
Top 42% in PA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
4
Companies
4
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$378 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$365
2021
$13

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Arcutis Biotherapeutics, Inc.
$153
Dermavant Sciences, Inc.
$114
Verrica Pharmaceuticals Inc.
$98
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2021-2024) ›
Arcutis Biotherapeutics, Inc.
$153
Dermavant Sciences, Inc.
$114
Verrica Pharmaceuticals Inc.
$98
Smith+Nephew, Inc.
$13
Top 3 companies account for 96.7% of all-time payments
Associated products mentioned in payments ›
COLLAGENASE SANTYL · VTAMA · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a nurse practitioner - family in Philadelphia?
Compare family nurse practitioners in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
2,326
Per 100K population
147.0
County median income
$60,698
Nearest hospital
ROXBOROUGH MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Newbold is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Newbold experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Newbold performed 3,884 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Newbold receive payments from pharmaceutical companies?
Yes. Dr. Newbold received a total of $378 from 4 companies across 4 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Newbold's costs compare to other family nurse practitioners in Philadelphia?
Dr. Newbold's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Newbold) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →